Hypersomnia
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and Idiopathic Hypersomnia
This activity is supported by educational grants from Harmony Biosciences and Jazz Pharmaceuticals.
LXB improves functional outcomes in patients with idiopathic hypersomnia
LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.
FDA approves Xywav for idiopathic hypersomnia in adults
The FDA approved a new indication for Xywav for the management of idiopathic hypersomnia in adults, according to a press release from the agency.
Hypersomnolence in older adults increases risk for multiple comorbidities
Older adults who reported hypersomnolence were more likely to have several other medical conditions, according to findings of a longitudinal study that will be presented at the American Academy of Neurology annual meeting this spring.
PCOS increases likelihood of eating, sleeping disorders
Women with polycystic ovary syndrome are more likely to have an eating or sleeping disorder and report decreased sexual satisfaction than those without PCOS, according to a meta-analysis of studies published in Clinical Endocrinology.